{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:17:57Z","timestamp":1790507877788,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:00:00Z","timestamp":1584748800000},"content-version":"vor","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA203257"],"award-info":[{"award-number":["CA203257"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA175105"],"award-info":[{"award-number":["CA175105"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32 DA016176"],"award-info":[{"award-number":["T32 DA016176"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CCSG","award":["P30CA177558"],"award-info":[{"award-number":["P30CA177558"]}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000117"],"award-info":[{"award-number":["UL1TR000117"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001998"],"award-info":[{"award-number":["UL1TR001998"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Kentucky College of Pharmacy"},{"name":"Markey Cancer Center"},{"name":"Office of the Vice President for Research"},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["P30CA177558"],"award-info":[{"award-number":["P30CA177558"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.chembiol.2018.11.013","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T12:05:15Z","timestamp":1547726715000},"page":"366-377.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS\/4E-BP1-Mediated Antitumor Effects"],"prefix":"10.1016","volume":"26","author":[{"given":"Qing","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiachang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa V.","family":"Ponomareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luksana","family":"Chaiswing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled A.","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiou","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley D.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daret K.","family":"St Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markos","family":"Leggas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon S.","family":"Thorson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7207-0599","authenticated-orcid":false,"given":"Qing-Bai","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2018.11.013_bib1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0092-8674(00)80584-X","article-title":"Bridge over troubled waters: sensing stress by disulfide bond formation","volume":"96","author":"Aslund","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2018.11.013_bib2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/jcb.21241","article-title":"Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines","volume":"101","author":"Bae","year":"2007","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.chembiol.2018.11.013_bib3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41416-018-0263-y","article-title":"Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents","volume":"119","author":"Bajor","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.chembiol.2018.11.013_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd4505","article-title":"Targeting the translation machinery in cancer","volume":"14","author":"Bhat","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2018.11.013_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13572","article-title":"eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies","volume":"513","author":"Boussemart","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2018.11.013_bib6","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.18632\/oncotarget.2109","article-title":"Loss of 4E-BP1 function induces EMT and promotes cancer cell migration and invasion via cap-dependent translational activation of snail","volume":"5","author":"Cai","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2018.11.013_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.canep.2009.08.006","article-title":"Preferential overexpression of glutaredoxin3 in human colon and lung carcinoma","volume":"33","author":"Cha","year":"2009","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.chembiol.2018.11.013_bib8","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.biocel.2008.10.029","article-title":"Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway","volume":"41","author":"Chen","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.chembiol.2018.11.013_bib9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijrobp.2005.10.012","article-title":"Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression","volume":"64","author":"Chen","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.chembiol.2018.11.013_bib10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4161\/cc.8.4.7659","article-title":"Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy","volume":"8","author":"Choo","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.chembiol.2018.11.013_bib11","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1126\/science.1187532","article-title":"mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs","volume":"328","author":"Dowling","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2018.11.013_bib12","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/onc.2013.92","article-title":"Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors","volume":"33","author":"Ducker","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.chembiol.2018.11.013_bib13","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1021\/ja01007a039","article-title":"The structure of frenolicin","volume":"90","author":"Ellestad","year":"1968","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2018.11.013_bib14","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.1000038","article-title":"Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2","volume":"7","author":"Feldman","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.chembiol.2018.11.013_bib15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ja.2011.94","article-title":"In\u00a0vitro and in\u00a0vivo activity of frenolicin B against Plasmodium falciparum and P berghei","volume":"64","author":"Fitzgerald","year":"2011","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.chembiol.2018.11.013_bib16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1089\/ars.2008.2291","article-title":"Mechanistic and kinetic details of catalysis of thiol-disulfide exchange by glutaredoxins and potential mechanisms of regulation","volume":"11","author":"Gallogly","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.chembiol.2018.11.013_bib17","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1021\/bi401034q","article-title":"Mechanistic basis for the potent anti-angiogenic activity of semaphorin 3F","volume":"52","author":"Guo","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2018.11.013_bib18","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1089\/ars.2012.4599","article-title":"Thioredoxins, glutaredoxins, and peroxiredoxins\u2013molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling","volume":"19","author":"Hanschmann","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.chembiol.2018.11.013_bib19","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1039\/b901735f","article-title":"Identification of conoidin a as a covalent inhibitor of peroxiredoxin II","volume":"7","author":"Haraldsen","year":"2009","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.chembiol.2018.11.013_bib20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bbrc.2010.03.016","article-title":"Characterization of the human monothiol glutaredoxin 3 (PICOT) as iron-sulfur protein","volume":"394","author":"Haunhorst","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chembiol.2018.11.013_bib21","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1091\/mbc.e12-09-0648","article-title":"Crucial function of vertebrate glutaredoxin 3 (PICOT) in iron homeostasis and hemoglobin maturation","volume":"24","author":"Haunhorst","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.chembiol.2018.11.013_bib22","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s00018-007-6554-8","article-title":"Monothiol glutaredoxins: a common domain for multiple functions","volume":"64","author":"Herrero","year":"2007","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.chembiol.2018.11.013_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2010.01.021","article-title":"Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E","volume":"17","author":"Hsieh","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chembiol.2018.11.013_bib24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1124\/pr.110.003459","article-title":"Prodrugs\u2014from serendipity to rational design","volume":"63","author":"Huttunen","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.chembiol.2018.11.013_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0968-0004(00)01685-6","article-title":"PICOT-HD: a highly conserved protein domain that is often associated with thioredoxin and glutaredoxin modules","volume":"25","author":"Isakov","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.chembiol.2018.11.013_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1200\/JCO.2005.09.078","article-title":"Prediction of docetaxel response in human breast cancer by gene expression profiling","volume":"23","author":"Iwao-Koizumi","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.chembiol.2018.11.013_bib27","first-page":"445","article-title":"Expression of peroxiredoxin 1 and 4 promotes human lung cancer malignancy","volume":"4","author":"Jiang","year":"2014","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.chembiol.2018.11.013_bib28","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1016\/S0021-9258(18)68840-4","article-title":"The isolation and purification of a specific \"protector\" protein which inhibits enzyme inactivation by a thiol\/Fe(III)\/O2 mixed-function oxidation system","volume":"263","author":"Kim","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2018.11.013_bib29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2018.11.013_bib30","doi-asserted-by":"crossref","first-page":"22011","DOI":"10.1074\/jbc.M610330200","article-title":"Human peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2","volume":"282","author":"Lee","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2018.11.013_bib31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/10715762.2018.1435871","article-title":"Glutaredoxin 3 promotes migration and invasion via the Notch signalling pathway in oral squamous cell carcinoma","volume":"52","author":"Li","year":"2018","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.chembiol.2018.11.013_bib32","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.bbagen.2008.06.003","article-title":"Glutaredoxin systems","volume":"1780","author":"Lillig","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.chembiol.2018.11.013_bib33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nchembio.935","article-title":"Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells","volume":"8","author":"Liu","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2018.11.013_bib34","doi-asserted-by":"crossref","first-page":"13962","DOI":"10.18632\/oncotarget.3920","article-title":"AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1\/4E-BP1 axis","volume":"6","author":"Mi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2018.11.013_bib35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.chembiol.2013.06.011","article-title":"Peroxiredoxin-1 from the human hookworm Ancylostoma ceylanicum forms a stable oxidized decamer and is covalently inhibited by conoidin A","volume":"20","author":"Nguyen","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2018.11.013_bib36","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.scitotenv.2009.12.005","article-title":"CO(2), CO, and Hg emissions from the truman shepherd and ruth mullins coal fires, eastern Kentucky, USA","volume":"408","author":"O'Keefe","year":"2010","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.chembiol.2018.11.013_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.03.018","article-title":"Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases","volume":"163","author":"Park","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.chembiol.2018.11.013_bib38","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bbapap.2014.11.011","article-title":"Redox proteomics reveal stress responsive proteins linking peroxiredoxin-1 status in glioma to chemosensitivity and oxidative stress","volume":"1854","author":"Poschmann","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.chembiol.2018.11.013_bib39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1172\/JCI43144","article-title":"Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-kappaB signaling","volume":"121","author":"Qu","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.chembiol.2018.11.013_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/15216540252774748","article-title":"Peroxiredoxin, a novel family of peroxidases","volume":"52","author":"Rhee","year":"2001","journal-title":"IUBMB Life"},{"key":"10.1016\/j.chembiol.2018.11.013_bib41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nmeth.1314","article-title":"SUnSET, a nonradioactive method to monitor protein synthesis","volume":"6","author":"Schmidt","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.chembiol.2018.11.013_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ccr.2010.05.023","article-title":"4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors","volume":"18","author":"She","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chembiol.2018.11.013_bib43","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1021\/jm960380s","article-title":"Structure-based design of a potent, selective, and irreversible inhibitor of the catalytic domain of the erbB receptor subfamily of protein tyrosine kinases","volume":"40","author":"Singh","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2018.11.013_bib44","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1158\/1535-7163.MCT-07-0211","article-title":"Discovery of lactoquinomycin and related pyranonaphthoquinones as potent and allosteric inhibitors of AKT\/PKB: mechanistic involvement of AKT catalytic activation loop cysteines","volume":"6","author":"Toral-Barza","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.chembiol.2018.11.013_bib45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2018.11.013_bib46","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1038\/s41467-017-02243-3","article-title":"Snail determines the therapeutic response to\u00a0mTOR kinase inhibitors by transcriptional repression of 4E-BP1","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2018.11.013_bib47","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1021\/ol4033418","article-title":"Ruthmycin, a new tetracyclic polyketide from Streptomyces sp. RM-4-15","volume":"16","author":"Wang","year":"2014","journal-title":"Org. Lett."},{"key":"10.1016\/j.chembiol.2018.11.013_bib48","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1021\/np400231r","article-title":"Frenolicins C-G, pyranonaphthoquinones from Streptomyces sp. RM-4-15","volume":"76","author":"Wang","year":"2013","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.chembiol.2018.11.013_bib49","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.radonc.2011.05.029","article-title":"Expression of thioredoxin system and related peroxiredoxin proteins is associated with clinical outcome in radiotherapy treated early stage breast cancer","volume":"100","author":"Woolston","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.chembiol.2018.11.013_bib50","doi-asserted-by":"crossref","first-page":"17809","DOI":"10.1073\/pnas.1414004111","article-title":"Self-assembled FUS binds active chromatin and regulates gene transcription","volume":"111","author":"Yang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.chembiol.2018.11.013_bib51","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1200\/JCO.2011.35.5263","article-title":"First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors","volume":"29","author":"Yap","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.chembiol.2018.11.013_bib52","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/onc.2013.122","article-title":"ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer","volume":"33","author":"Ye","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.chembiol.2018.11.013_bib53","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/ncb2822","article-title":"A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS","volume":"15","author":"Zhang","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.chembiol.2018.11.013_bib54","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1021\/ol4027649","article-title":"A diastereoselective oxa-Pictet-Spengler-based strategy for (+)-frenolicin B and epi-(+)-frenolicin B synthesis","volume":"15","author":"Zhang","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.chembiol.2018.11.013_bib55","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1002\/anie.201505022","article-title":"A divergent enantioselective strategy for the synthesis of griseusins","volume":"54","author":"Zhang","year":"2015","journal-title":"Angew. Chem. Int. Ed."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945618304355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945618304355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:33:38Z","timestamp":1762526018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945618304355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S2451945618304355"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2018.11.013","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frenolicin B Targets Peroxiredoxin 1 and Glutaredoxin 3 to Trigger ROS\/4E-BP1-Mediated Antitumor Effects","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2018.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}